Next Article in Journal
Olaparib Conjugates with Selenopheno[3,2-c]quinolinone Inhibit PARP1 and Reverse ABCB1-Related Multidrug Resistance
Next Article in Special Issue
Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility
Previous Article in Journal
Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers
Previous Article in Special Issue
Behavior of Regular Insulin in a Parenteral Nutrition Admixture: Validation of an LC/MS-MS Assay and the In Vitro Evaluation of Insulin Glycation
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(12), 2570; https://doi.org/10.3390/pharmaceutics14122570
Action Date Notes Link
article xml file uploaded 23 November 2022 09:40 CET Original file -
article xml uploaded. 23 November 2022 09:40 CET Update https://www.mdpi.com/1999-4923/14/12/2570/xml
article pdf uploaded. 23 November 2022 09:40 CET Version of Record https://www.mdpi.com/1999-4923/14/12/2570/pdf
article supplementary file uploaded. 23 November 2022 09:40 CET - https://www.mdpi.com/1999-4923/14/12/2570#supplementary
article html file updated 23 November 2022 09:41 CET Original file -
article html file updated 1 March 2023 00:26 CET Update -
article html file updated 3 March 2023 22:11 CET Update https://www.mdpi.com/1999-4923/14/12/2570/html
Back to TopTop